Zhaoke Ophthalmology Ltd.

As of December 31, 2025, Zhaoke Ophthalmology Ltd. carries a market capitalization of 1.62B, placing it among publicly traded companies globally. Its enterprise value stands at 878.07M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Zhaoke Ophthalmology Ltd.'s next confirmed earnings release is scheduled for March 29, 2027.

As of December 31, 2025, Zhaoke Ophthalmology Ltd. has 547.97M shares outstanding.

These figures are as of December 31, 2025.

As of December 31, 2025, Zhaoke Ophthalmology Ltd. maintains a current ratio of 4.18, meaning it holds 4.2x the short-term assets needed to cover near-term liabilities.

These figures cover the twelve months ended December 31, 2025.

As of the close on October 22, 2026, Zhaoke Ophthalmology Ltd.'s stock has declined approximately 38.99% over the past 52 weeks. The 50-day moving average sits at 2.44, while the 200-day moving average is 2.83.

As of December 31, 2025, Zhaoke Ophthalmology Ltd. holds 1.07B in cash and equivalents against 325.36M in total debt, resulting in a net debt position of -766.71M. Total book value stands at 1.75B, with working capital of 1.16B providing operational flexibility.